dipyridamole has been researched along with Diathesis in 3 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipyridamole use was related to a lower risk of lymphoid neoplasms, indicating a clinical potential of dipyridamole to be an adjunct anti-tumour agent against lymphoid neoplasms." | 1.72 | Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score-matched cohort study. ( Huang, W; Ji, J; Sundquist, J; Sundquist, K, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, W | 1 |
| Sundquist, K | 1 |
| Sundquist, J | 1 |
| Ji, J | 1 |
| Herzog, CA | 1 |
| Liao, JK | 1 |
1 review available for dipyridamole and Diathesis
| Article | Year |
|---|---|
Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?
Topics: Aspirin; Atherosclerosis; Cilostazol; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Dipyr | 2007 |
2 other studies available for dipyridamole and Diathesis
| Article | Year |
|---|---|
Use of dipyridamole is associated with lower risk of lymphoid neoplasms: a propensity score-matched cohort study.
Topics: Aged; Aged, 80 and over; Aspirin; Chemoprevention; Comorbidity; Dipyridamole; Disease Susceptibility | 2022 |
Stress imaging in renal transplant candidates.
Topics: Adult; Atropine; Blood Pressure; Coronary Disease; Dipyridamole; Disease Susceptibility; Dobutamine; | 2004 |